Asma, Lesley Anya M.

HRN: 26-92-64  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2026
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
02/25/2026
03/04/2026
PO
2ml
Q8
PCAP
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines